InvestorsHub Logo
Followers 165
Posts 13286
Boards Moderated 0
Alias Born 03/06/2011

Re: chineerat post# 736

Wednesday, 01/25/2012 12:37:02 PM

Wednesday, January 25, 2012 12:37:02 PM

Post# of 923
News Breaks
January 23, 2012
09:16 EDT YMI
theflyonthewall.com: YM Biosciences reported compelling data, says Roth Capital
Roth Capital believes that YM reported differentiated efficacy data, especially with regard to positive anemia responses, at ASH. The firm thinks that the company will land a major partnership n 1H12 and it reiterates a $6 target and Buy rating on the stock.

YMI should start a new move higher....rare

All my posts are my opinions. Investors should do there own DD!!